JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB97175

Goat Anti-Human IgG H&L (HRP) preadsorbed

Goat Anti-Human IgG H&L (HRP) preadsorbed

Be the first to review this product! Submit a review

|

(16 Publications)

Suitable for ICC, IHC-P, ELISA, WB. Ideal for western blot. Preadsorbed to minimise non-specific binding and high background staining. Cited in 16 publications.

查看别名

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1, Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4, Immunoglobulin heavy constant gamma 3, HDC, Heavy chain disease protein, Ig gamma-3 chain C region, IGHG3, Immunoglobulin heavy constant gamma 2, Ig gamma-2 chain C region, Ig gamma-2 chain C region DOT, Ig gamma-2 chain C region TIL, Ig gamma-2 chain C region ZIE, IGHG2

关键信息

宿主种属

Goat

靶标种属

Human

靶标亚型

IgG

靶标特异性

Heavy & Light chains

最低交叉反应

Mouse, Rat, Rabbit, Horse, Chicken, Cow, Pig

预吸附

Yes

偶联物

HRP

激发波长/发射波长
应用

WB, ICC, IHC-P, ELISA

applications

克隆

Polyclonal

亚型

IgG

特异性

By immunoelectrophoresis and ELISA this antibody reacts specifically with Human IgG and with light chains common to other Human immunoglobulins. No antibody was detected against non immunoglobulin serum proteins. Reduced cross-reactivity to bovine, chicken, goat, horse, mouse, pig, rabbit and rat was detected.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ICC": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "IHC-P": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/200 - 1/5000", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/10000 - 1/100000", "notes":"<p>ELISA-Primary</p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/5000 - 1/50000", "notes":"<p>WB-Colorimetric 1/5000 - 1/30000; WB-Chemiluminescent 1/10000 - 1/50000</p>" } } }

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Immunogen
纯化说明
Antiserum was cross adsorbed using bovine, chicken, horse, mouse, pig, rabbit and rat immunosorbents to remove cross reactive antibodies. This antibody was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to Horse Radish Peroxidase (HRP).
存储溶液
pH: 6.8 - 7.4 Preservative: 0.05% CMIT/MIT based preservative Constituents: 0.2% BSA
运输条件
Blue Ice
推荐的短期储存条件
+4°C
推荐的长期储存条件
+4°C

产品实验方案

靶点信息

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region of Ig gamma-1 (IgG1) isotype interacts (via the fragment crystallizable, Fc) with receptors on innate immune cells and the complement system to mediate humoral effector functions, including antibody-dependent cellular cytotoxicity or phagocytosis, complement-dependent cytotoxicity and inflammatory responses.
See full target information IGHG1

其他靶点

IGHG4,IGHG2,IGHG3

文献 (16)

Recent publications for all applications. Explore the full list and refine your search

Emerging microbes & infections 14:2544720 PubMed40793825

2025

Preexisting yellow fever virus and West Nile virus immunity and pregnancy outcomes in a Nigerian cohort with endemic orthoflavivirus exposure.

Applications

Unspecified application

Species

Unspecified reactive species

Taewoo Kim,Bobby Brooke Herrera,Beth Chaplin,Kailee Naito-Keoho,Jerry Ogwuche,Atiene S Sagay,Charlotte Ajeong Chang,Donald J Hamel,Wei-Kung Wang,Phyllis J Kanki

Science advances 11:eadw0698 PubMed40540557

2025

Monoclonal antibodies targeting the FimH adhesin protect against uropathogenic UTI.

Applications

Unspecified application

Species

Unspecified reactive species

Edward D B Lopatto,Jesús M Santiago-Borges,Denise A Sanick,Sameer Kumar Malladi,Philippe N Azimzadeh,Morgan W Timm,Isabella F Fox,Aaron J Schmitz,Jackson S Turner,Shaza M Sayed Ahmed,Lillian Ortinau,Nathaniel C Gualberto,Jerome S Pinkner,Karen W Dodson,Ali H Ellebedy,Andrew L Kau,Scott J Hultgren

Frontiers in cellular and infection microbiology 15:1445660 PubMed40171164

2025

Divergent host humoral innate immune response to the smooth-to-rough adaptation of in chronic infection.

Applications

Unspecified application

Species

Unspecified reactive species

Emily A Wheeler,Patricia M Lenhart-Pendergrass,Noel M Rysavy,Katie R Poch,Silvia M Caceres,Kara M Calhoun,Karina A Serban,Jerry A Nick,Kenneth C Malcolm

eLife 12: PubMed38716629

2024

Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies.

Applications

Unspecified application

Species

Unspecified reactive species

Xiuyuan Lu,Hiroki Hayashi,Eri Ishikawa,Yukiko Takeuchi,Julian Vincent Tabora Dychiao,Hironori Nakagami,Sho Yamasaki

mAbs 15:2254676 PubMed37698877

2023

Discovery and characterization of prolactin neutralizing monoclonal antibodies for the treatment of female-prevalent pain disorders.

Applications

Unspecified application

Species

Unspecified reactive species

Stephanie Maciuba,Gregory D Bowden,Harrison J Stratton,Kazimierz Wisniewski,Claudio D Schteingart,Juan C Almagro,Philippe Valadon,Joshua Lowitz,Scott M Glaser,Grace Lee,Mahdi Dolatyari,Edita Navratilova,Frank Porreca,Pierre J M Rivière

Microbiology spectrum 11:e0327922 PubMed36651756

2023

Deficient Complement Opsonization Impairs Mycobacterium avium Killing by Neutrophils in Cystic Fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Patricia M Lenhart-Pendergrass,Kenneth C Malcolm,Emily Wheeler,Noel M Rysavy,Katie Poch,Silvia Caceres,Kara M Calhoun,Stacey L Martiniano,Jerry A Nick

Small (Weinheim an der Bergstrasse, Germany) 18:e2203309 PubMed36036173

2022

Enhanced Enzymatically Amplified Metallization on Nanostructured Surfaces for Multiplexed Point-of-Care Electrical Detection of COVID-19 Biomarkers.

Applications

Unspecified application

Species

Unspecified reactive species

Neda Rafat,Hanhao Zhang,Josiah Rudge,Yoo Na Kim,Sai Preetham Peddireddy,Nabojeet Das,Aniruddh Sarkar

Microbiology spectrum 10:e0187422 PubMed35863022

2022

Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Kenneth C Malcolm,Emily A Wheeler,Kara Calhoun,Patricia M Lenhart-Pendergrass,Noel Rysavy,Katie R Poch,Silvia M Caceres,Milene T Saavedra,Jerry A Nick

Cell 185:1860-1874.e12 PubMed35568033

2022

Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection.

Applications

Unspecified application

Species

Unspecified reactive species

Jerry A Nick,Rebekah M Dedrick,Alice L Gray,Eszter K Vladar,Bailey E Smith,Krista G Freeman,Kenneth C Malcolm,L Elaine Epperson,Nabeeh A Hasan,Jo Hendrix,Kimberly Callahan,Kendra Walton,Brian Vestal,Emily Wheeler,Noel M Rysavy,Katie Poch,Silvia Caceres,Valerie K Lovell,Katherine B Hisert,Vinicius Calado de Moura,Delphi Chatterjee,Prithwiraj De,Natalia Weakly,Stacey L Martiniano,David A Lynch,Charles L Daley,Michael Strong,Fan Jia,Graham F Hatfull,Rebecca M Davidson

Scientific reports 10:15171 PubMed32938950

2020

An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA.

Applications

Unspecified application

Species

Unspecified reactive species

Nishant Mehta,Sainiteesh Maddineni,Ryan L Kelly,Robert B Lee,Sean A Hunter,John L Silberstein,R Andres Parra Sperberg,Caitlyn L Miller,Amanda Rabe,Louai Labanieh,Jennifer R Cochran
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com